- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 4, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A newsletter from NYU Langone Health referenced a video interview published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The interview, “Amivantamab Presents an Exciting Treatment Opportunity in NSCLC,” featured an interview with Joshua K. Sabari, MD, to speak about the 2 FDA approvals for amivantamab to treat non–small cell lung cancer.
An article from Becker’s GI & Endoscopy referenced an article published on AJMC.com. The article, “Updated Colonoscopy Guidelines Have Implications on Doctors, Patients Alike,” featured interviews with the coauthor of the American College of Gastroenterology and American Society for Gastrointestinal Endoscopy colonoscopy guidelines as well as a doctor from Vanderbilt University Medical Center to discuss the implications of the new guidelines and what to expect once they are implemented.
An article from Pharmacy Times referenced an article published AJMC’s sister site, The Center for Biosimilars®. The article, “FDA Approves First Stelara Biosimilar,” reported on the FDA approval of ustekinumab-auub to treat moderate to severe plaque psoriasis, active psoriatic arthritis, Crohn disease, and moderately to severely active ulcerative colitis.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Radiation Bridging Therapy Boosts CAR T Outcomes in R/R LBCL
April 3rd 2025In this comparative analysis, patients with relapsed/refractory large B-cell lymphoma (R/R LBCL) received bridging therapy via radiation or systemic treatment while their chimeric antigen receptor T-cell therapy (CAR T) was being manufactured.
Read More
